Sort
261,768 grants matching “gene therapy”
Pulmonary pathophysiology sub-phenotypes of pneumonia
$856,279Joseph P Mizgerd · Boston University Medical Campus · R01 · FY2022 · AI
CTL for supertype natural IgE cytotoxic peptide (nECP) to guard against allergic asthma
$856,276Swey-Shen Chen · Ige Therapeutics, Inc. · R44 · FY2017 · AI
Entry and replication of positive-sense, RNA viruses
$856,275Joseph Marcotrigiano · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
STudy of Acute HIV for investiGating Eradication Strategies (STAGES): The role of IL-10 and IFN signaling
$856,202Sulggi Angela Lee · University Of California, San Francisco · R01 · FY2025 · AI
Omics Analyses of HIV and Substance Use Disorder
$856,189Vez Repunte-Canonigo · Scripps Research Institute, The · R01 · FY2020 · DA
Omics Analyses of HIV and Substance Use Disorder
$856,189Vez Repunte-Canonigo · Scripps Research Institute, The · R01 · FY2021 · DA
Preclinical Development of SB 44 as an Orally Bioavailable Anti-HBV Agent
$856,160Radhakrishnan P Iyer · Spring Bank Technologies, Inc. · R01 · FY2014 · AI
Pediatric Heart Disease: Getting from Mutations to Therapeutics
$856,106Bruce D Gelb · Icahn School Of Medicine At Mount Sinai · R35 · FY2017 · HL
Interdisciplinary Small Animal Imaging for Oncology
$856,091Johns Hopkins University · R24 · FY2002 · CA
Cellular Interactions with Thrombospondin
$856,071David D Roberts · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
The effects of cART and HIV-1 infection on neural circuitry
$856,064Grigori N Enikolopov · State University New York Stony Brook · R01 · FY2024 · MH
Transformative Computational Infrastructures for Cell-Based Biomarker Diagnostics
$855,992Richard H Scheuermann · J. Craig Venter Institute, Inc. · U01 · FY2016 · TR
Evaluation of Vectors based on group B adenoviruses
$855,992Andre Michael Lieber · University Of Washington · R01 · FY2013 · CA
AAV-mediated gene therapy for GM2-gangliodoses
$855,961Miguel S Esteves · Univ Of Massachusetts Med Sch Worcester · U01 · FY2010 · NS
AAV-mediated gene therapy for GM2-gangliodoses
$855,961Miguel S Esteves · Univ Of Massachusetts Med Sch Worcester · U01 · FY2010 · NS
Regulation of CTCF Functions and Target Sites by Cancer/Testis-specific CTCF Like BORIS Factor
$855,918Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
The Study of HIV Infection in the Etiology of Lung Disease (SHIELD)
$855,897Gregory D Kirk · Johns Hopkins University · R01 · FY2007 · HL
Membrane protein target for leukemia therapy
$855,881Xunlei Kang · University Of Missouri-Columbia · R37 · FY2025 · CA
Inflammation of Myofibroblasts and Loss of Elastic Recoil in Severe Asthma
$855,867Sally E Wenzel · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · HL
Genome-Wide Association Study in African-Americans with Rheumatoid Arthritis
$855,820S Louis Bridges · University Of Alabama At Birmingham · R01 · FY2009 · AR
Xenobiotic Receptors in Mediating the Environmental Effects on Human Disease and Morbidity
$855,738Wen Xie · University Of Pittsburgh At Pittsburgh · R35 · FY2023 · ES
Angiogenesis and Tumor Growth
$855,728Giovanna Tosato · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA
Omics Analyses of HIV and Substance Use Disorder
$855,649Vez Repunte-Canonigo · Scripps Research Institute, The · R01 · FY2019 · DA
Role of cellular senescence in cardiovascular aging
$855,648Simon Melov · Buck Institute For Research On Aging · R01 · FY2021 · AG
SPORE in Pancreatic Cancer
$855,582Donald J. Buchsbaum · University Of Alabama At Birmingham · P20 · FY2007 · CA